Bristol-Myers Squibb and Catalent close Italian manufacturing deal

Former BMS manufacturing and packaging facility in Anagni is now under Catalent ownership

picture of

Breaking News

US gene therapy CDMO enters virus manufacturing partnership

Vigene Biosciences will provide manufacturing services for ASC for both early-stage and commercial virus production

Argonaut launches aseptic vial filling services for biopharmaceuticals

A California-based CDMO has designed an aseptic filling line to maximise yield of expensive biologics and other high- ...

Tessa to build commercial-scale cell therapy production site in Singapore

The clinical-stage cell therapy company plans to open a 90,000 square foot facility by year-end

Manufacturing Chemist roundtable: Pharmaceutical trends to keep an eye on

From cannabis to containment and from regulatory affairs to Russia, 2019 presented the pharmaceutical industry with a ...

WuXi STA opens oligonucleotide large-scale manufacturing facility

API production at the Changzhou site can manufacture oligonucleotide ingredients up to 1 mol/synthesis run

Boehringer is first to take advantage of new Chinese regulations

Tislelizumab is the first biopharmaceutical manufactured by a multinational CDMO in China and the first commissioned ...

Super early bird tickets now on sale for Manufacturing Chemist Live 2020

Manufacturing Chemist Live will provide guidelines and regulations for delegates seeking solutions to optimise ...

AGC expands plasmid DNA capacity in Germany

ACG’s Heidelberg site has completed a pDNA manufacturing process improvement project that expands the service in ...

Chinese government recognises Catalent

The Chinese government has acknowledged Catalent’s successful investment and operations in the Tangzhen region

Expanded access and commercial packaging for niche-market drugs

Securing timely and reliable commercial packaging services can be challenging for orphan, niche and other low-volume ...

Almac FAST: Continuous flow chemistry with assisted synthesis technology

Flow assisted synthesis technology (FAST) is a unique flow chemistry platform for continuous production of chemicals ...

Future innovations in pharmaceutical contract manufacturing

In the final part of our roundtable, panellists look at current drivers and assess the long-term interest in on-trend ...

Swedish biotech chooses Recipharm for sepsis drug manufacturing

Recipharm has signed a deal with Aptahem to develop an injectable formulation for an upcoming Phase 1 study

Catalent makes deals for opoid and CBD products

Agreements will see Bridge Therapeutics employ Catalent’s Zydis Ultra technology to allow an increased drug load and ...